Analysis Demonstrates Predictive Capacity of 4 Staging Systems for Cutaneous Squamous Cell Carcinoma
Staging systems were analyzed for specificity, positive predictive value, negative predictive value, concordance index, and other parameters.
Melanoma
Chemotherapy ‘Has Limited Role’ After ICI Failure in Metastatic Melanoma
The objective response rate was 12.5%, and the median progression-free survival was 2.6 months.
Sunburn Diagnosis More Prevalent in Obese Individuals
The relationship between obesity and sunburn diagnosed during a medical examination is examined.
Apps Have Low Accuracy and Sensitivity for Detecting Melanoma
The accuracy of dermatology apps in detecting melanoma is investigated.
FDA-Approved Melanoma Treatments
FDA-approved drug therapies for cutaneous melanoma.
Many Oncology Drugs Approved for Genomic Indications Not Studied for Overall Survival Outcomes
Overall survival data were available for about half of the drugs.
Patient-Led Surveillance Shows Potential in Posttreatment Care of Localized Melanoma
A pilot randomized clinical trial compared a patient-led intervention with usual care for patients with prior primary melanoma.
Risk of Nonmelanoma Skin Cancer Associated With Exposure to Ruxolitinib
Results of a 10-year retrospective study suggests a higher risk of nonmelanoma skin cancer in patients with polycythemia vera or myelofibrosis after ruxolitinib exposure.
Melanomas Detected in Routine Skin Checks Associated With Significantly Lower All-Cause Mortality
Melanoma-specific and all-cause mortality linked with melanomas found during skin checks is examined.
Keytruda Approved for Adjuvant Treatment IIB, IIC Melanoma Following Resection
Approval was based on data from the phase 3 KEYNOTE-716 trial, which enrolled 976 participants.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...